VOLITIONRX LTD — Director's Dealing 2019

Feb 27, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2019-02-25

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-25	Common Stock	X	11000	$2.2	Acquired	22000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-25	Warrant (Right to Buy)	$2.2	X	11000	Disposed	2019-02-26	Common Stock (11000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	38113	Indirect
Common Stock	86166	Direct

Footnotes

F1: The Reporting Person's wife exercised a warrant to purchase 11,000 shares of Common Stock of the issuer for $2.20 per share. The warrant was set to expire pursuant to its terms on February 26, 2019.

F2: The shares of Common Stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares, but disclaims beneficial ownership of the shares of Common Stock, except to the extent of his pecuniary interest therein.